Mon panier

Vitronectin

Vitronectin Informations sur la molécule

Nom anglaisVitronectinNombre de médicaments commercialisés0
Nombre de médicaments cliniques0Alias de la cibleVitronectin,V75,VN,Serum-spreading factor,Vitronectin (Serum Spreading Factor, Somatomedin B, Complement S-Protein),Somatomedin B,Epibolin,Serum Spreading Factor,VNT,S-protein,Complement S-Protein,Protein S
Phase de R&D la plus avancéePreclinical
Nom anglaisVitronectin
Alias de la cibleVitronectin,V75,VN,Serum-spreading factor,Vitronectin (Serum Spreading Factor, Somatomedin B, Complement S-Protein),Somatomedin B,Epibolin,Serum Spreading Factor,VNT,S-protein,Complement S-Protein,Protein S
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques0
Phase de R&D la plus avancéePreclinical

Vitronectin Liste de produits

  • Attribut

    Protein (4)Kits (1)

  • Bibliothèque de produits

    En ligne (5)

  • Espèces

    Human (5)

  • Étiquette

    Tag Free (4)- (1)

  • Marqueur

    Unconjugated (4)- (1)

VitronectinContexte de la molécule

Vitronectin is also known as S-protein, VN, VTN, V75. Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes. Blocking of Hic(a member of the pneumococcal surface protein C (PspC) family) by specific antiserum or genetic deletion significantly reduced pneumococcal binding to soluble and immobilised vitronectin and to Factor H, respectively. In addition, Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway.

VitronectinAlias de la molécule

VTN,V75,VN,Vitronectin,S-protein,Serum-spreading factor
  • Informations sur la molécule
  • Liste de produits